Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variabil
- PDF / 1,541,137 Bytes
- 15 Pages / 595.276 x 790.866 pts Page_size
- 15 Downloads / 176 Views
REVIEW ARTICLE
Transcriptional and post‑transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism Tomas Smutny1 · Lucie Hyrsova1 · Albert Braeuning2 · Magnus Ingelman‑Sundberg3 · Petr Pavek1 Received: 1 July 2020 / Accepted: 17 September 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract The pregnane X receptor (PXR, encoded by the NR1I2 gene) is a ligand-regulated transcription factor originally described as a master regulator of xenobiotic detoxification. Later, however, PXR was also shown to interact with endogenous metabolism and to be further associated with various pathological states. This review focuses predominantly on such aspects, currently less covered in literature, as the control of PXR expression per se in the context of inter-individual differences in drug metabolism. There is growing evidence that non-coding RNAs post-transcriptionally regulate PXR. Effects on PXR have especially been reported for microRNAs (miRNAs), which include miR-148a, miR-18a-5p, miR-140-3p, miR-30c-1-3p and miR-877-5p. Likewise, miRNAs control the expression of both transcription factors involved in PXR expression and regulators of PXR function. The impact of NR1I2 genetic polymorphisms on miRNA-mediated PXR regulation is also discussed. As revealed recently, long non-coding RNAs (lncRNAs) appear to interfere with PXR expression. Reciprocally, PXR activation regulates non-coding RNA expression, thus comprising another level of PXR action in addition to the direct transactivation of proteincoding genes. PXR expression is further controlled by several transcription factors (cross-regulation) giving rise to different PXR transcript variants. Controversies remain regarding the suggested role of feedback regulation (auto-regulation) of PXR expression. In this review, we comprehensively summarize the miRNA-mediated, lncRNA-mediated and transcriptional regulation of PXR expression, and we propose that deciphering the precise mechanisms of PXR expression may bridge our knowledge gap in inter-individual differences in drug metabolism and toxicity. Keywords Pregnane X receptor · Gene expression · Non-coding RNA · microRNA · Post-transcriptional regulation · CYP3A4 Abbreviations 3′-UTR 3′-Untranslated region AF Activation function domain AHR Aryl hydrocarbon receptor CAR Constitutive androstane receptor CYP Cytochrome P450 DBD DNA-binding domain * Tomas Smutny [email protected] 1
Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
2
Department Food Safety, German Federal Institute for Risk Assessment, Max‑Dohrn‑Str. 8‑10, 10589 Berlin, Germany
3
Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Solna vägen 9, 17165 Stockholm, Sweden
DME Drug-metabolizing enzyme DR1 Direct repeat 1 ERα Estrogen receptor α GR Glucocorticoid receptor HNF1α Hepatocyte nuclear fact
Data Loading...
